Home › Research › Topics › metabolism
metabolism
13 studies tagged metabolism, dated 1997-01-01 to 2025-02-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- SSRIs reduce plasma tau and restore dorsal raphe metabolism in Alzheimer's disease 2025-02-01
- Multi-omics data reveals aberrant gut microbiota-host glycerophospholipid metabolism in association with neuroinflammation in APP/PS1 mice 2023-11-22
- Effect of the ABCA1 agonist CS-6253 on amyloid-β and lipoprotein metabolism in cynomolgus monkeys 2022-06-24
Studies
13 studies carry this tag.
Date range
1997 to 2025
Top journals
- Neurobiology of disease 2
- Acta neuropathologica 1
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Alzheimer's research & therapy 1
- Cell reports 1
12 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Long-term SSRI use may reduce the pathological presentation of AD but has variable effects on cognitive performance.
-
Numerous studies have described the notable impact of gut microbiota on the brain in Alzheimer's disease (AD) via the gut - brain axis.
-
43/100
Treatment with the ABCA1 agonist CS-6253 appears to favor Aβ clearance from the brain.
-
Alzheimer's disease (AD) risk gene ApoE4 perturbs brain lipid homeostasis and energy transduction.
-
Microglia are universal sensors of alterations in CNS physiology.
-
Perturbations in iron homeostasis and iron accumulation feature in several neurodegenerative disorders including Alzheimer's disease (AD), Parkinson's disease (PD) and Amyotrophic lateral sclerosis (ALS).
-
Genome-wide association studies (GWASs) have identified 19 susceptibility loci for Alzheimer's disease (AD).
-
Abberant lipid metabolism is implicated in Alzheimer's disease (AD) pathophysiology, but the connections between AD and lipid metabolic pathways are not fully understood.
-
Disturbed homocysteine metabolism is a risk factor for Alzheimer's disease (AD) and may contribute to the disease pathophysiology by increasing both amyloid-beta (Abeta) production and phosphorylated tau (P-tau) accumulation.
-
Amyloid beta peptide (Abeta) has a key role in the pathological process of Alzheimer's disease (AD), but the physiological function of Abeta and of the amyloid precursor protein (APP) is unknown.
-
Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD).
-
The epsilon4 allele of apolipoprotein E (apoE) is a risk factor for Alzheimer's disease (AD), perhaps through effects on amyloid-beta (Abeta) metabolism.
-
Pharmacological doses of zinc cause neuronal death, and some estimates indicate that extracellular concentrations of zinc could reach neurotoxic levels under pathological conditions.